Sarepta Crashes After Second Death On Gene Therapy Drug

zerohedge.com/markets/sarepta-crashes-after-second-death-gene-therapy-drug

Sarepta Crashes After Second Death On Gene Therapy Drug

Sarepta Therapeutics shares suffered their steepest drop in years on Monday morning after a second teenage patient died following treatment with Elevidys, the biotech's one-time gene therapy for Duchenne muscular dystrophy…

This story appeared on zerohedge.com, 2025-06-16 17:25:00.
The Entire Business World on a Single Page. Free to Use →